As of 2024-12-12, the EV/EBITDA ratio of KemPharm Inc (KMPH) is -6.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KMPH's latest enterprise value is 153.95 mil USD. KMPH's TTM EBITDA according to its financial statements is -23.90 mil USD. Dividing these 2 quantities gives us the above KMPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 9.8x | 8.5x |
| Forward P/E multiples | 13.1x - 19.1x | 16.3x |
| Fair Price | (7.74) - (5.47) | (7.24) |
| Upside | -233.2% - -194.1% | -224.6% |
| Date | EV/EBITDA |